Literature DB >> 9781511

Management issues for women with epilepsy: a review of the literature.

C A Zahn1, M J Morrell, S D Collins, D M Labiner, M S Yerby.   

Abstract

OBJECTIVE: A review of literature referable to management issues for women with epilepsy (WWE) was undertaken for the development of a practice parameter.
BACKGROUND: Epilepsy is a common neurologic condition with gender-related management implications. Although reviews of this topic often focus on pregnancy-related issues for WWE, specific health concerns for WWE are present throughout all phases of reproductive life.
METHODS: An OVID MEDLINE literature search was conducted for 1965 to 1997 using the following key words/phrases and cross referencing: epilepsy/ seizures and pregnancy, anticonvulsants, antiepileptic drugs (AEDs), teratogenesis, oral contraceptives, birth defects, folate/folic acid, vitamin K, metabolic bone disease, and breast-feeding.
RESULTS: Pregnancy outcome literature for WWE spans several decades. Methodology varies and interpretation is complicated by modern management strategies. Contributions of socioeconomic factors, AEDs, maternal epilepsy, and seizures during pregnancy to adverse pregnancy outcomes have not been clearly delineated. There is a biologic basis for recommendations concerning contraception, folate supplementation, vitamin K use in pregnancy, breast-feeding, metabolic bone disease, catamenial epilepsy, and reproductive endocrine disorders, but no outcome studies afford a strong evidence base for practice recommendation.
CONCLUSIONS: WWE face health issues for which there is no available outcome literature to guide decision making. The urgent need for studies in many of these areas is highlighted by expanded treatment options with new AEDs and epilepsy surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781511     DOI: 10.1212/wnl.51.4.949

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Managing women with epilepsy. Guideline producers now need to pay attention to implementation.

Authors:  S Wiebe
Journal:  BMJ       Date:  2000-01-01

2.  Primary Generalized Epilepsies.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

3.  Using current evidence in selecting antiepileptic drugs for use during pregnancy.

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

4.  The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study.

Authors:  Silva Burja; Zlatka Rakovec-Felser; Milena Treiber; Dusanka Hajdinjak; Marijana Gajsek-Marchetti
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

5.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

6.  Epilepsy in Pregnant Women.

Authors:  Michiko Kimura Bruno; Cynthia L. Harden
Journal:  Curr Treat Options Neurol       Date:  2002-01       Impact factor: 3.598

Review 7.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 8.  Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?

Authors:  Page B Pennell
Journal:  Epilepsia       Date:  2008-12       Impact factor: 5.864

Review 9.  Pregnancy, epilepsy, and anticonvulsants.

Authors:  Bernhard J Steinhoff
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

10.  Expectations prior to epilepsy surgery: an exploratory comparison of men and women.

Authors:  C M Bower; R D Hays; O Devinsky; S S Spencer; M R Sperling; S Haut; S Vassar; B G Vickrey
Journal:  Seizure       Date:  2008-10-15       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.